MIT Develops Implantable Device for Glioblastoma Drug Delivery

MIT researchers have engineered an implantable device designed to deliver drugs for glioblastoma, an aggressive brain cancer. This technology features a reservoir for sustained drug release and ultrasound transducers to enhance drug spread and bypass the blood-brain barrier. The device aims to target remaining tumor cells by gradually releasing medication after surgical implantation, potentially improving treatment outcomes for this challenging disease.